Andere talen Immatics N.V.

Aandelen

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 25-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
9,78 ^USD	-3,65%		-4,68%	-7,12%

21/03	Sectorupdate: Gezondheidszorgaandelen stijgen donderdag voor de beurs	MT
21/03	Sectorupdate: Gezondheidszorg	MT

Certain Ordinary Shares of Immatics N.V. are subject to a Lock-Up Agreement Ending on 17-APR-2024.	17/04
Certain Warrants of Immatics N.V. are subject to a Lock-Up Agreement Ending on 17-APR-2024.	17/04
Certain Options of Immatics N.V. are subject to a Lock-Up Agreement Ending on 17-APR-2024.	17/04
Sector Update: Health Care Stocks Gain Pre-Bell Thursday	21/03
Sector Update: Health Care	21/03
Immatics Swings to 2023 Net Loss, Revenue Falls -- Shares Down Pre-Bell	21/03
Immatics N.V. Reports Earnings Results for the Full Year Ended December 31, 2023	21/03
Immatics N : Corporate Presentation March 2024	21/03
Immatics Announces Full Year 2023 Financial Results and Corporate Update	21/03
Sector Update: Health Care Stocks Mixed Premarket Thursday	18/01
Immatics Prices $175 Million Share Offering	18/01
Immatics Announces Pricing of $175 Million Public Offering	18/01
Immatics Announces Pricing of $175 Million Public Offering	18/01
Immatics Plans Common Stock Offering	17/01
Immatics Announces Proposed Public Offering	17/01
Immatics Announces Proposed Public Offering	17/01
Immatics: Q3 Earnings Snapshot	14/11
Immatics N.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Immatics Announces Third Quarter 2023 Financial Results and Business Update	14/11
Immatics Reports Interim Clinical Data from ACTengine IMA203 and IMA203CD8 TCR-T Monotherapies Targeting PRAME in an Ongoing Phase 1 Trial	09/11

Geen resultaten voor deze zoekopdracht